Home 2022

Randomized controlled trial

Cognitive and Motor Functions May Improve with Neflamapimod
Drug Discovery

Cognitive and Motor Functions May Improve with Neflamapimod

Anjali A. Sarkar, PhD -
0
Todos Medical – Tollovir™ (NLC-V-01)
News

Todos Medical – Tollovir™ (NLC-V-01)

Alex Philippidis -
0
Ion Channel in Brain May Serve as Novel Target for Treating Depression
News

Ion Channel in Brain May Serve as Novel Target for Treating Depression

John Sterling -
0
Trends and Takeaways from J.P. Morgan 2021
GEN Edge Live

Trends and Takeaways from J.P. Morgan 2021

Kathy Vuksanaj -
1
FDA Repeals Emergency Use Authorization for Hydroxychloroquine, Chloroquine
Coronavirus

FDA Repeals Emergency Use Authorization for Hydroxychloroquine, Chloroquine

Alex Philippidis -
1
German Primate Center-Leibniz Institute for Primate Research, University of Aarhus, and partner institutions
News

German Primate Center-Leibniz Institute for Primate Research, University of Aarhus, and partner institutions

Alex Philippidis -
0
Mateon Therapeutics
News

Mateon Therapeutics

Alex Philippidis -
0
Merck & Co., Ridgeback Biotherapeutics, and Drug Innovations at Emory (DRIVE) – Molnupiravir (MK-4482, EIDD-2801)
News

Merck & Co., Ridgeback Biotherapeutics, and Drug Innovations at Emory (DRIVE) – Molnupiravir (MK-4482, EIDD-2801)

Alex Philippidis -
0
RedHill Biopharma – Opaganib (Yeliva®, ABC294640)
News

RedHill Biopharma – Opaganib (Yeliva®, ABC294640)

Alex Philippidis -
0
Pfizer – PAXLOVID™ (nirmatrelvir; PF-07321332)
News

Pfizer – PAXLOVID™ (nirmatrelvir; PF-07321332)

Alex Philippidis -
2
123...5Page 1 of 5
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.